AbbVie Inc. insider trading

Bought

—

Sold

$18.9M

4 of 6 on a 10b5-1 plan

Net

−$18.9M

Insiders

3

• Donoghoe Nicholas

  EVP, Chief Bus/strat Officer

  −$8.2M

  Aug 14, 2026

  32,710 sh · $250.00

• Purdue David Ryan

  SVP, Controller

  −$1.2M

  Mar 04, 2026

  5,230 sh · $233.56

• Siatis Perry C10b5-1

  EVP, GC And Secretary

  −$1.3M

  Mar 02, 2026

  5,777 sh · $233.51

• Siatis Perry C10b5-1

  EVP, GC And Secretary

  −$2.4M

  Mar 02, 2026

  10,291 sh · $234.66

• Siatis Perry C10b5-1

  EVP, GC And Secretary

  −$611.7K

  Mar 02, 2026

  2,600 sh · $235.26

• Siatis Perry C10b5-1

  EVP, GC And Secretary

  −$5.1M

  Feb 25, 2026

  22,381 sh · $230.00

Largest sale

−$49.5M of ABBV by Gonzalez Richard A (Executive Chairman Of Board · Director) on Jul 17, 2024, under a 10b5-1 plan.

From SEC's quarterly Form 3, 4 and 5 data sets: code P purchases and code S sales of common stock, by the date the trade happened. Where a fund and the people who control it each report the same block, it is counted once. Trades made in the last days of Q2 2026 but filed after it closed arrive with SEC's next quarterly release.

SEC industry classification

Pharmaceutical Preparations

Headquarters

North Chicago, IL

Incorporated in

DE

Listed on

NYSE

SEC Central Index Key

0001551152

Sourced from this company's own SEC submissions record. The industry label is SEC's Standard Industrial Classification, which is more specific than the Health Care sector shown above.

The live dashboard is free to open. Alerts, watchlists, full filing history and each mover's benchmark-measured track record are Pro. Monitoring, not advice.

Open-market purchase (code P)

An insider spending their own money at market price. This is the only buy code that reliably carries signal — it is a decision, not compensation.

Grants and option exercises (codes A, M)

Scheduled compensation. Most "insider buying" headlines are really this, which is why InsiderPulse weights it at a fraction of a real purchase.

Cluster buy

Two or more different insiders buying on the open market in the same window. One executive buying can mean anything; three is much harder to explain away.

Are ABBV insiders buying or selling?

Between Feb 25, 2026 and Aug 14, 2026, 3 AbbVie Inc. insiders made no open-market purchases and 6 sales worth $18.9M, a net sale of $18.9M. 4 of the sales were pre-scheduled under a Rule 10b5-1 plan.

How much ABBV stock have insiders bought and sold in the last two years?

Between Jul 01, 2024 and Jun 30, 2026, 9 AbbVie Inc. insiders made no open-market purchases and 33 sales worth $141.7M. 20 of the sales were pre-scheduled under a Rule 10b5-1 plan. In the four quarters to Jun 30, 2026: no purchases and 8 sales ($21.8M). The largest sale was Gonzalez Richard A selling $49.5M on Jul 17, 2024.

What was the largest recent ABBV insider trade?

Donoghoe Nicholas (EVP, Chief Bus/strat Officer) sold $8.2M of ABBV stock on Aug 14, 2026 at about $250.00 a share.

When did an insider last buy ABBV shares?

No open-market purchase by a AbbVie Inc. insider appears in the filings from Feb 25, 2026 to Aug 14, 2026 — every recorded open-market transaction in that period was a sale.

Where does ABBV insider trading data come from?

From the Form 4 filings AbbVie Inc.'s officers, directors and 10% owners must send the SEC within two business days of a trade. Each row on this page links to its original filing on SEC EDGAR. Share grants and option exercises are kept apart from open-market purchases and sales, because only the latter cost the insider their own money.